Seattle Genetics? Not anymore. The biotech has shortened its name to Seagen to illustrate global expansion

The biotech announced Thursday it’s changing its name to Seagen, capping off what’s been a 12-month period in which it closed a $4.5 billion deal with Merck and saw two drugs get FDA approval. Seagen is also keeping the same Wall Street ticker — $SGEN.